Brenntag AG (BNR) Receives Average Recommendation of “Buy” from Analysts

Brenntag AG (FRA:BNR) has received a consensus recommendation of “Buy” from the sixteen research firms that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is €53.52 ($62.23).

BNR has been the topic of a number of research reports. Deutsche Bank set a €49.00 ($56.98) target price on shares of Brenntag and gave the company a “buy” rating in a research report on Wednesday, January 23rd. Jefferies Financial Group set a €51.00 ($59.30) target price on shares of Brenntag and gave the company a “neutral” rating in a research report on Thursday, March 14th. Baader Bank set a €50.00 ($58.14) target price on shares of Brenntag and gave the company a “buy” rating in a research report on Thursday, April 11th. Berenberg Bank set a €60.00 ($69.77) target price on shares of Brenntag and gave the company a “buy” rating in a research report on Wednesday, May 15th. Finally, Goldman Sachs Group set a €55.00 ($63.95) target price on shares of Brenntag and gave the company a “buy” rating in a research report on Wednesday, March 6th.

Brenntag stock traded up €0.12 ($0.14) during trading hours on Friday, reaching €45.40 ($52.79). 190,297 shares of the company’s stock traded hands. Brenntag has a fifty-two week low of €43.06 ($50.07) and a fifty-two week high of €56.25 ($65.41).

About Brenntag

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

See Also: How to execute a trade ex-dividend strategy?

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.